RankAlpha logo
Back to Rankings

RLYB

RallybioF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
RLYB vs peer average
31/100
RLYB vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 1 · D 4 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ANTX is the first available peer comparator.

Small-cap clinical-stage biotech with comparable market cap and rare-disease/clinical development risk profile.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerANTXAN2 Therapeutics
RLYB
Rallybio
ANTX
AN2 Therapeutics
Grade
F
B
Momentum
88
99
Value
41
41
Sentiment
0
38
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs ANTX

RLYB / ANTX
Grade Position
Below peers
RLYB vs. peer average (F vs. D)
31/100
Momentum
88
ANTX
Value
41
RLYB
Sentiment
0
ANTX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RLYB
1
ANTX
ANTX
B
80/100
-3
2
MRKR
MRKR
C
60/100
-2
3
VTGN
VTGN
F
20/100
Even
4
ATHE
Alteriry Therapeutics Ltd ADR
F
20/100
Even
5
CGTX
Cognition Therapeutics Inc Common
D
40/100
-1
ANTX is the first peer returned for this comparison set.